Financials

  • Market Capitalization 471.88 M
  • Employee 102
  • Founded 2010
  • CEO Brian Stuglik
  • Website www.verastem.com
  • Headquarter Massachusetts, United States
  • FIGI BBG001J2LSK5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.56
Price to sales ratio
17.31

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2951
OCGN
Ocugen, Inc. - Common Stock
1.41 USD-4.08%-6.62%+11.02%+25.89%477.32 M USD
2960
KYTX
Kyverna Therapeutics, Inc. - Common Stock
7.77 USD-8.48%-14.99%-5.47%+75.79%472.38 M USD
2974
PRTA
Prothena Corporation plc - Ordinary Shares
8.83 USD-4.44%-8.21%+0.68%+37.11%462.28 M USD
2977
STRO
Sutro Biopharma, Inc. - Common Stock
27.84 USD-6.36%-10.19%-3.33%+60.09%461.32 M USD

Frequently asked questions about Verastem, Inc. - Common Stock

What is the Verastem, Inc. - Common Stock stock price today?

The current price of Verastem, Inc. - Common Stock (VSTM) is 5.37. Over the past 24 hours, the stock has changed by -2.89%. Follow the VSTM chart for real-time price dynamics.

What is the stock ticker of Verastem, Inc. - Common Stock?

Verastem, Inc. - Common Stock trades under the ticker VSTM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Verastem, Inc. - Common Stock stock going up?

VSTM has changed by +19.60% over the last week, +29.09% over the last month, and +7.83% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Verastem, Inc. - Common Stock net income for the last quarter?

Verastem, Inc. - Common Stock reported net income of -36.59 M for the last quarter. The previous quarter showed -32.92 M, which means net income changed by -11.16%.

How many employees does Verastem, Inc. - Common Stock have?

As of the latest available data, Verastem, Inc. - Common Stock has 102 employees. Workforce size can provide additional context about the company's scale and operations.

What is Verastem, Inc. - Common Stock EBITDA?

Verastem, Inc. - Common Stock EBITDA is -44.46 M, and its EBITDA margin is -238.11%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Verastem, Inc. - Common Stock stock?

You can buy Verastem, Inc. - Common Stock (VSTM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Verastem, Inc. - Common Stock stock?

Investing in Verastem, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VSTM chart and related analysis on metatrader.com as part of your research.

Verastem, Inc. - Common Stock

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

News